KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Sales (2016 - 2026)

Edwards Lifesciences has reported Return on Sales over the past 17 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, down 1.0%, while the annual FY2025 figure was 0.0%, 1.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.0% at Edwards Lifesciences, up from 0.0% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.02% in Q3 2024 and troughed at 0.0% in Q1 2025.
  • A 5-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: grew 2bps in 2024 and later fell -2bps in 2025.
  • Year by year, Return on Sales stood at 0.0% in 2021, then soared by 85bps to 0.0% in 2022, then plummeted by -94bps to 0.0% in 2023, then decreased by -2bps to 0.0% in 2024, then tumbled by -39bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for EW at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.